Stearoylethanolamide (SEA) is an endocannabinoid neurotransmitter.
Stearoylethanolamide (CHNO; 18:0), also called N-(octadecanoyl)ethanolamine, is an N-acylethanolamine and the ethanolamide of octadecanoic acid (CHO; 18:0) and ethanolamine (MEA: CHNO), and functionally related to an octadecanoic acid.
Levels of SEA correlate with changes in pain intensity, indicating this SEA change, reflect the pain reduction effects of IPRP.